Paxman
57.00 SEK
0.00 %
Less than 1K followers
PAX
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
0.00 %
-10.94 %
-27.48 %
-31.82 %
-13.11 %
-12.31 %
+30.43 %
+148.91 %
+422.94 %
Paxman is active in scalp cooling, which is used for patients undergoing chemotherapy. The company's product Paxman Scalp Cooler is used to minimize hair loss in patients during treatment. The Scalp Cooler is a freestanding, mobile and electrically powered cooling unit that cools the patient's scalp via a cooling cap. Paxman was founded in 1996 and is headquartered in Karlshamn.
Read moreMarket cap
1.33B SEK
Turnover
2.97M SEK
Revenue
253.01M
EBIT %
13.24 %
P/E
27.01
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27.2
2026
Annual report '25
21.5
2026
Interim report Q1'26
22.5
2026
General meeting '26
All
Press releases
ShowingAll content types
Correction: Further updated Information on OPPS Reimbursement
Correction: Updated Information on OPPS Reimbursement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools